Rallybio revs up antibody discovery activities
Rallybio has become the latest company to hitch its antibody drug development efforts to AbCellera. The partners will co-develop up to five rare disease therapeutic targets...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Rallybio has become the latest company to hitch its antibody drug development efforts to AbCellera. The partners will co-develop up to five rare disease therapeutic targets...
We are excited to be back in person for the largest industry networking event in the state! Join the celebration and congratulate the 2022 Entrepreneur of the...
Here is this year’s list from FiercePharma of the 20 fiercest women in life sciences. Female representation remains depressingly low in the highest offices of the pharma,...
View this email in your browser Weekly Roundup – December 1, 2022 The 2022 Marcum Year-End Tax Guide provides an overview of many of the issues affecting...
New Haven-based BioXcel Therapeutics has begun treating patients in a trial of its drug designed to treat agitation associated with bipolar disorder and schizophrenia. Dr. Robert Risinger, chief...
Here’s a message from BIO about drug prices. The latest health sector economic indicators from Altarum demonstrate that healthcare prices continue to grow slower than inflation—and prescription...
Bio-Techne has opened a new 52,000-square-foot production and manufacturing facility in Wallingford, doubling the size of its existing facility. The expansion increases the company’s production capacity...
Torigen Pharmaceuticals, a commercial-stage animal health company in Farmington, has closed on a $13 million round of venture capital financing. Ashley Kalinauskas, CEO and co-founder...
Biohaven Ltd., formerly known as Biohaven Pharmaceutical Holding Company Ltd., officially launched Oct. 4 after an $11.6 billion acquisition deal with Pfizer closed. Since then, Biohaven...
Trevi Therapeutics has named Dr. David Clark as its new chief medical officer. Clark has more than 25 years of global clinical development experience in big...